April 21, 2010

Prodo Labs and the Scharp-Lacy Research Institute collaborate to increase the numbers of high quality human islets for distribution through a new contract with the National Institute for Diabetes, Digestive, and Kidney Diseases (NIDDK) of the National Institutes of...

October 15, 2009

Prodo Labs announces cut back in activities due to reduced islet orders from the economic turndown. With slow down in the economy, major corporate pharmaceutical companies are changing their priorities in their research operations and reducing the number of human...

March 18, 2009

Prodo Labs presented at the Rochmeil Levine Symposium A paper entitled, “USE OF ROCHE cGMP LIBERASE® MTF C/T IN ISLET ISOLATION FROM HUMAN PANCREAS WITH EXTENDED COLD ISCHEMIA TIME (CIT), was presented at the City of Hope annual Levine Symposium. It demonstrated...

July 1, 2008

Prodo Labs announces that its contracts for the distribution of human islets for research have reached pharmaceutical companies with a total annual R&D budget of $26 Billion. Prodo Labs provides human islets for research to biotechnology and pharmaceutical...

June 23, 2008

The Scharp –Lacy Institute replaces the Invenio Institute and takes control of its contract with the JDRF to supply human islets for research to its funded investigators. Invenio Institute has decided to change its name to The Scharp-Lacy Research Institute to capture...

April, 2008

Invenio Institute Awarded Contract by Juvenile Diabetes Research Foundation (JDRF) to Distribute Human Islets for Research to Their Funded Investigators. The JDRF has renewed a contract with Invenio Institute to distribute human islets which had distributed 5 million...